Skip to content

Modification to Zargis Acoustic Cardioscan (ZAC)

by Zargis Medical Corp. 510(k)

Active United States

510(k) K042128

Overview

This device is an electronic stethoscope, specifically a modification to the Zargis Acoustic Cardioscan (ZAC), intended to provide support to the physician in the evaluation of heart sounds in patients. It is classified as a Class II medical device under FDA regulation 870.1875 with product code DQD.

The device was cleared via the FDA 510(k) process under submission K042128 on September 8, 2004, and is substantially equivalent to a predicate device. It is manufactured by Zargis Medical Corp. in Princeton, New Jersey, and is designated for cardiovascular use.

AI-generated from registry data, 24 Sep 2026.Not verified by deviCERTS or the manufacturer

Regulatory status

as of 28 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Special NumberK042128 Date8 Sep 2004ClearedStatusActive

Coverage

1 jurisdiction

United States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not known
  • Not covered

United States — FDA 510(k) Active

Recalls

0 recalls · FDA

No FDA recalls on record, checked 22 Oct 2026.

Specification

510(k)

510(k) Number
FDA Product Code
DQD
Device Class
Class II
Regulation
21 CFR Part 870.1875
Advisory Committee
Cardiovascular
FDA Decision
SESE Substantially Equivalent

Other devices from Zargis Medical Corp.

Questions

  • What is the Modification to Zargis Acoustic Cardioscan (ZAC) used for?

    It is an electronic stethoscope intended to provide support to physicians in the evaluation of heart sounds in patients, specifically designed for cardiovascular assessment as indicated in its FDA 510(k) submission.

  • How was the Modification to Zargis Acoustic Cardioscan (ZAC) cleared for market?

    The device was cleared via the FDA 510(k) process under submission K042128 on September 8, 2004, as substantially equivalent to a predicate device, which is the regulatory pathway referenced in its authorization data.

  • Who manufactures the Modification to Zargis Acoustic Cardioscan (ZAC) and where is it located?

    The device is manufactured by Zargis Medical Corp., with its address listed as 755 College Rd. E., Princeton, NJ 08540, United States, as specified in the device’s registration and contact details.